MIRA Pharmaceuticals, Inc. (MIRA)

NASDAQ: MIRA · IEX Real-Time Price · USD

0.689

-0.097 (-12.37%)

At close: Jul 19, 2024, 4:00 PM

1.350

+0.661 (95.99%)

Pre-market: Jul 22, 2024, 9:23 AM EDT

MIRA Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-12.36	-11.98	-7.06	-2.18
Share-Based Compensation	2.9	2.55	1.3	0
Other Operating Activities	4.95	4.9	0.16	0.8
Operating Cash Flow	-4.51	-4.53	-5.6	-1.38
Share Issuance / Repurchase	7.7	7.7	2.9	4.51
Debt Issued / Paid	0.14	0.94	0.29	0.2
Other Financing Activities	0.19	0.14	-0.04	-0.53
Financing Cash Flow	8.03	8.78	3.15	4.18
Net Cash Flow	3.53	4.25	-2.46	2.81
Free Cash Flow	-4.51	-4.53	-5.6	-1.38
Free Cash Flow Per Share	-0.23	-0.24	-0.32	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).